The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D Infection

Clinical trial NCT04638439 · COMPLETED

Trial details

NCT number: NCT04638439
Sponsor: PharmaEssentia
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Hepatitis B Infection Chronic Hepatitis D Infection

Start date: 2022-08-17
Primary completion: 2026-04-08
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.